Chantix Is Gone: The Best Alternatives for Quitting in 2026

If you’ve searched for a Chantix alternative recently, you already know the situation. Pfizer permanently discontinued brand-name Chantix (known as Champix in the UK, EU, and most of the world) in 2023, and the supply problem hasn’t resolved — it’s gotten worse. Generic varenicline remains unavailable or severely restricted in the UK, EU, Japan, and several other markets. The most effective single quit-smoking medication ever developed is, for millions of people, simply gone.

This isn’t a temporary shortage. Champix is discontinued for good. And the consequences are measurable: a 2024 study in The Lancet estimated that the loss of varenicline access causes 1,890+ extra avoidable deaths per year in the UK alone. That figure accounts only for the gap between varenicline’s efficacy and the next best available option — it doesn’t capture the people who tried nothing at all because they’d been told “just wait for Champix to come back.”

It’s not coming back. So let’s talk about what actually works instead.

Why Chantix/Champix Was Discontinued

Pfizer pulled Chantix from shelves in mid-2021 after detecting elevated levels of N-nitrosodimethylamine (NDMA), a probable carcinogen, in some batches. What was initially framed as a precautionary recall turned into a permanent exit. Pfizer confirmed in 2023 that it would not resume manufacturing.

The discontinuation had nothing to do with efficacy. Varenicline remains the most effective single pharmacotherapy for smoking cessation, with Cochrane reviews showing approximately 22–23% abstinence at one year versus 8–10% for placebo. It works by partially activating the same nicotinic receptors that cigarettes and vapes stimulate, reducing cravings whilst simultaneously blocking nicotine’s reward signal if you do relapse.

The problem was manufacturing, not medicine. But that distinction means nothing if you can’t get the drug.

The Current Varenicline Availability Map (2026)

Generic varenicline exists — but access is wildly uneven.

Region	Status (as of early 2026)
United States	Generic varenicline available from multiple manufacturers. Supply is stable but can vary by pharmacy.
Canada	Generic available. Some intermittent supply issues in rural areas.
United Kingdom	Effectively unavailable. NHS stopped routinely prescribing in 2022.
European Union	Unavailable in most member states. Some grey-market importation.
Japan	Unavailable. No approved generic.
Australia	Limited availability via specific pharmacies. PBS listing remains but stock is unreliable.
India	Generic available and affordable.

If you’re in the US or Canada and can access generic varenicline, it remains the first-line recommendation. Ask your GP or pharmacist. If you’re in the UK, EU, or Japan, read on — the rest of this guide is written with you in mind.

Alternative 1: Cytisine — The “New” Drug That’s Actually 60 Years Old

Cytisine might be the most important development in smoking cessation since varenicline itself. It’s a plant-derived alkaloid from the golden rain tree (Cytisus laburnum), and it works through the same mechanism as varenicline: partial agonism of α4β2 nicotinic acetylcholine receptors. In fact, varenicline was modelled on cytisine’s structure.

Cytisine has been used in Eastern Europe — particularly Poland, Bulgaria, and Russia — since the 1960s under the brand name Tabex. Tens of millions of courses have been prescribed. The safety profile is well established.

What’s changed: In 2024–2025, cytisine received regulatory approval in the UK (marketed as Asmoken) and is currently undergoing review for broader European and potential FDA approval. For UK residents, this is the single most significant Champix replacement available.

The evidence:

• A 2023 Cochrane review of 10 trials found cytisine significantly increases quit rates versus placebo (RR 1.30–1.74 depending on the trial design)
• A landmark NEJM trial (Hajek et al., 2023) directly compared cytisine to NRT in 1,266 participants. At six months, cytisine showed non-inferior — and numerically superior — quit rates
• Cost per course: roughly £20–£50, versus £100+ for a 12-week varenicline course

Dosing protocol: Cytisine follows a 25-day stepped course, starting at 6 tablets per day and reducing to 1–2 by the final week. It’s shorter and simpler than the standard 12-week varenicline course.

Side effects: Nausea and gastrointestinal discomfort (similar to varenicline but generally milder), headache, dry mouth. Contraindicated in pregnancy.

The bottom line: If you’re in the UK and your GP hasn’t mentioned cytisine, ask about it. It’s the closest pharmacological equivalent to the drug you lost.

Alternative 2: Bupropion (Zyban / Wellbutrin)

Bupropion is a norepinephrine–dopamine reuptake inhibitor. It was originally developed as an antidepressant (Wellbutrin), and its anti-smoking properties were discovered when depressed smokers taking it spontaneously quit.

It works differently from varenicline and cytisine. Rather than targeting nicotinic receptors directly, bupropion increases dopamine and norepinephrine availability in the brain, partially compensating for the neurochemical deficit that makes quitting so hard. It also acts as a mild antagonist at nicotinic receptors, which may reduce the reward from smoking.

The evidence:

• Cochrane review (2024): bupropion approximately doubles quit rates versus placebo (RR ~1.60)
• Real-world one-year success rates: approximately 18–23%
• The EAGLES trial (NEJM, 2016) found bupropion’s efficacy slightly below varenicline’s but with no significant difference in neuropsychiatric adverse events

Practical advantages:

• Widely available globally — no supply crisis
• Helps with depression and anxiety during cessation (both extremely common)
• May reduce weight gain during quitting (one of the few cessation aids with this property)
• Can be combined with NRT for additive benefit

Practical disadvantages:

• Prescription only
• Takes 1–2 weeks to reach therapeutic levels (start before your quit date)
• Lowers the seizure threshold — contraindicated if you have a seizure disorder or history of eating disorders
• Insomnia and dry mouth are common side effects

Dosing: Typically 150mg once daily for 3 days, then 150mg twice daily for 7–12 weeks. Your GP sets the quit date for week 2, once bupropion has reached effective blood levels.

Bupropion is available in the UK, EU, US, Canada, Australia, and most markets. It’s not as effective as varenicline was, but it’s the strongest widely available prescription option.

Alternative 3: Nicotine Replacement Therapy (NRT)

NRT remains the most accessible cessation aid on the planet. Patches, gum, lozenges, inhalers, and nasal sprays are available over the counter in most countries without a prescription. We’ve written a comprehensive NRT guide that covers every form, dosing protocol, and common mistake — read that for the full picture.

Here’s the summary relevant to the Chantix gap:

Single NRT product: Increases quit rates by 50–60% versus placebo (Cochrane, 2018). Real-world one-year success rate: approximately 7–10%.

Combination NRT (patch + fast-acting form): Roughly doubles effectiveness compared to a single product. A background patch handles baseline cravings; gum or lozenges handle the spikes. This combination approach is the most under-used strategy in smoking cessation — it’s recommended in clinical guidelines but rarely explained to patients.

Why NRT underperforms varenicline: Varenicline blocks the nicotinic receptor’s reward response, meaning that if you slip and smoke, you don’t get the usual hit. NRT doesn’t do this. You can smoke on a patch and still feel the cigarette. This difference matters for relapse prevention.

Where NRT shines: Accessibility. No prescription. No supply crisis. Available in every pharmacy in every country. If you combine NRT with behavioural support — a quit-smoking app, counselling, or a structured programme — your success rate rises to 15–20%, approaching bupropion territory.

Alternative 4: Behavioural Support and Quit-Smoking Apps

Here’s a statistic that surprises most people: behavioural support alone (no medication) achieves quit rates of 7–16% at one year (PMC review, 2024). That’s comparable to single-product NRT. And when you combine behavioural support with any pharmacotherapy, success rates increase across the board.

The effect nicotine has on your brain creates both a chemical dependency and a behavioural one. Medication addresses the chemical side. Behavioural support addresses the triggers, routines, identity shifts, and psychological patterns that keep people smoking even when they know it’s killing them.

Effective behavioural support includes:

• Quit-smoking apps that provide structured daily support, craving tracking, and milestone reinforcement
• Telephone quitlines (free in most countries — NHS Smokefree in the UK, 1-800-QUIT-NOW in the US)
• Brief GP counselling — even 3–5 minutes of advice from a doctor increases quit rates by 30%
• Cognitive behavioural therapy (CBT) — the most evidence-backed psychological approach for addiction
• Group programmes — social support and accountability

The evidence is unambiguous: combining methods works better than any single approach. If you’ve lost access to varenicline, the most effective replacement isn’t a single alternative — it’s a combination. Bupropion or cytisine plus NRT plus behavioural support approaches the efficacy that varenicline achieved alone.

The Combination Strategy: Building Your Own Protocol

Since no single alternative matches varenicline’s efficacy, the smartest approach is stacking. Here’s a framework based on the current evidence:

Tier 1 (strongest available): Cytisine (if accessible) OR bupropion + combination NRT (patch + gum/lozenges) + behavioural support (app or counselling)

Tier 2 (strong, no prescription needed): Combination NRT (patch + fast-acting form) + behavioural support + structured quit plan

Tier 3 (no medication): Cold turkey + intensive behavioural support + clear relapse plan

Each tier is legitimate. Cold turkey with support works — we cover it in depth in our cold turkey vs. tapering analysis. The key is matching the approach to your dependency level and preferences, then adding support layers rather than relying on a single method.

For a step-by-step framework regardless of which method you choose, see our complete guide to quitting smoking.

What About Vaping as a Quit-Smoking Aid?

This is the most contentious question in cessation science. The short answer: some evidence supports e-cigarettes as more effective than NRT for quitting smoking (Hajek et al., NEJM, 2019), but you’re trading one nicotine addiction for another. Public Health England’s position (vaping is 95% less harmful than smoking) is not universally shared — the WHO and several national health agencies remain cautious.

We won’t recommend swapping one dependency for another. If you’re considering vaping as a bridge, be aware that most people who switch to vaping do not subsequently quit vaping. The goal is to be free of nicotine entirely, not to find a marginally less harmful delivery system.

The Financial Angle

Quitting smoking saves money regardless of which cessation method you use. A 20-a-day habit in the UK costs roughly £5,000 per year at current prices. In the US, it’s $3,000–$4,000 depending on state taxes.

Even the most expensive cessation protocol — 12 weeks of bupropion plus combination NRT plus a paid app — costs a fraction of a year’s smoking. Most cost nothing: NRT is free on NHS prescription in the UK, and bupropion is covered by most insurance plans in the US.

Curious how much you’d save? Run your numbers through our savings calculator. The results tend to be sobering.

Frequently Asked Questions

Is generic varenicline the same as Chantix?

Yes. Generic varenicline tartrate is the same active ingredient, same dose, same mechanism of action. It simply isn’t manufactured by Pfizer and doesn’t carry the Chantix/Champix brand name. Bioequivalence testing is required before generic approval. The clinical effect is identical.

Why can’t I get varenicline in the UK?

Pfizer’s discontinuation removed the only approved manufacturer. For a generic to be sold in the UK, it must receive MHRA approval, and manufacturers must establish UK-specific supply chains. As of early 2026, no generic manufacturer has completed this process for the UK market. Cytisine (Asmoken) is the recommended pharmacological alternative.

Is cytisine as effective as varenicline?

Head-to-head data is limited, but the available evidence suggests cytisine is slightly less effective than varenicline in controlled trials whilst remaining significantly better than placebo and broadly comparable to NRT. Its advantages are cost (roughly one-fifth the price) and availability. A direct equivalence trial is underway but results aren’t expected until 2027.

Can I combine bupropion with NRT?

Yes. Multiple trials support this combination, and clinical guidelines in the US, UK, and Australia endorse it. The combination is more effective than either alone. Discuss dosing and monitoring with your GP, as bupropion is prescription-only and has specific contraindications.

What’s the single best alternative to Chantix in 2026?

There is no single equivalent. The closest pharmacological match is cytisine (where available) or generic varenicline (in the US/Canada). The most effective overall strategy is combining pharmacotherapy (bupropion or cytisine) with combination NRT and behavioural support. This multi-layered approach can match or exceed the quit rates varenicline achieved as a standalone treatment.

Should I wait for varenicline to become available again?

No. Every day you continue smoking causes cumulative, measurable harm. The alternatives outlined above are effective. Waiting for a drug that has no confirmed return date is not a cessation strategy — it’s a delay tactic your addiction is happy to exploit.

What to Do Right Now

If you were planning to quit with Chantix or Champix and just learned it’s gone, here’s your immediate action plan:

1. Book a GP appointment. Ask specifically about cytisine (UK) or bupropion. Mention that you’re seeking a varenicline alternative — this frames the conversation correctly.

2. Start combination NRT today. You don’t need a prescription. Buy a 21mg patch and 4mg gum or lozenges. Use the patch for background coverage and the gum for craving spikes. This gets nicotine replacement running whilst you wait for your GP appointment.

3. Get behavioural support. Download a quit-smoking app. Call your national quitline. Tell someone you’re quitting. Accountability and structure matter more than most people realise.

4. Set a quit date within the next two weeks. Not “someday.” Not “when I’m ready.” A specific date. Write it down. The research is clear: people who set quit dates are significantly more likely to follow through.

5. Track what you’ll save. Use our savings calculator to see the financial impact. Money is a surprisingly effective motivator when the health arguments feel abstract.

If you want structured daily support through the process — something that adapts to your cravings, tracks your progress, and keeps you accountable — join Cravo. We’re building exactly this, grounded in the same evidence base this article draws from.

---

“The secret of getting ahead is getting started.” — Mark Twain

This article is for informational purposes only and does not constitute medical advice. Varenicline, cytisine, and bupropion are prescription medications with specific contraindications and side effects. Consult a qualified healthcare professional before starting any cessation pharmacotherapy. If you experience severe mood changes, suicidal thoughts, or allergic reactions whilst taking any cessation medication, seek immediate medical attention.